Showing 1 - 14 results of 14 for search 'Angela Williams', query time: 0.05s
Refine Results
-
1
Carer burden in rare inherited diseases: a literature review and conceptual model by Kerry Sandilands, Angela Williams, Angela J. Rylands
Published 2022-12-01
Article -
2
Craniosynostosis in Patients With X‐Linked Hypophosphatemia: A Review by Craig F Munns, Edward P Maguire, Angela Williams, Sue Wood, Andrew Biggin
Published 2023-05-01
Article -
3
-
4
-
5
AL amyloid imaging and therapy with a monoclonal antibody to a cryptic epitope on amyloid fibrils. by Jonathan S Wall, Stephen J Kennel, Angela Williams, Tina Richey, Alan Stuckey, Ying Huang, Sallie Macy, Robert Donnell, Robin Barbour, Peter Seubert, Dale Schenk
Published 2012-01-01
Article -
6
A binding-site barrier affects imaging efficiency of high affinity amyloid-reactive peptide radiotracers in vivo. by Jonathan S Wall, Angela Williams, Tina Richey, Alan Stuckey, Ying Huang, Craig Wooliver, Sallie Macy, Eric Heidel, Neil Gupta, Angela Lee, Brianna Rader, Emily B Martin, Stephen J Kennel
Published 2013-01-01
Article -
7
A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH)... by Vrinda Saraff, Annemieke M Boot, Agnès Linglart, Oliver Semler, Pol Harvengt, Angela Williams, Karen M A Bailey, Fiona Glen, Elin Haf Davies, Sue Wood, Stephen Greentree, Angela J Rylands
Published 2024-01-01
Article -
8
Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral Amyloidosis by Jonathan S. Wall, Emily B. Martin, Tina Richey, Alan C. Stuckey, Sallie Macy, Craig Wooliver, Angela Williams, James S. Foster, Penney McWilliams-Koeppen, Ed Uberbacher, Xiaolin Cheng, Stephen J. Kennel
Published 2015-04-01
Article -
9
Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes. by Helen P McWilliams-Koeppen, James S Foster, Nicole Hackenbrack, Marina Ramirez-Alvarado, Dallas Donohoe, Angela Williams, Sallie Macy, Craig Wooliver, Dale Wortham, Jennifer Morrell-Falvey, Carmen M Foster, Stephen J Kennel, Jonathan S Wall
Published 2015-01-01
Article -
10
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults by Helen L. Stacey, Jeffrey Rosen, James T. Peterson, Angela Williams-Diaz, Vanita Gakhar, Tina M. Sterling, Camilo J. Acosta, Katrina M. Nolan, Jianing Li, Alison Pedley, Patrice Benner, Chitrananda Abeygunawardana, Michael Kosinski, William J. Smith, Hari Pujar, Luwy K. Musey
Published 2019-03-01
Article -
11
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment by Karine Briot, Wei Sun, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Peter Kamenický, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Robin H Lachmann, Annabel Nixon, Mark Nixon, Anne-Lise Lecoq, Sami Kolta, Jennifer S Walsh, Angela J Rylands
Published 2023-02-01
Article -
12
Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT) by Matthew G. Johnson, Julie M. Strizki, Erin Jensen, Jonathan Cohen, Christine Katlama, Roman Fishchuk, Alfredo Ponce-de-León, Nyda Fourie, Chien-Yu Cheng, Dorothy McCoy, Mary Vesnesky, Carmelle T. Norice, Ying Zhang, Angela Williams-Diaz, Michelle L. Brown, Patricia Carmelitano, Jay A. Grobler, Amanda Paschke, Carisa De Anda
Published 2024-03-01
Article -
13
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data by Gema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M. Boot, Maria Luisa Brandi, Karine Briot, Carmen de Lucas Collantes, Francesco Emma, Sandro Giannini, Dieter Haffner, Richard Keen, Elena Levtchenko, Outi Mӓkitie, M. Zulf Mughal, Ola Nilsson, Dirk Schnabel, Liana Tripto-Shkolnik, Jonathan Liu, Angela Williams, Sue Wood, M. Carola Zillikens
Published 2023-09-01
Article -
14
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension by Karine Briot, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Han-Wook Yoo, Peter Kamenický, Takuo Kubota, Nobuaki Ito, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Hiroyuki Tanaka, Robin H Lachmann, Karl Insogna, Richard Eastell, Yasuhiro Takeuchi, Anthony A Portale, Thomas O Carpenter, Hae Ii Cheong, Yasuo Imanishi, Steven Ing, Suzanne Jan de Beur, Farzana Perwad, Pisit Pitukcheewanont, Thomas J Weber, Annabel Nixon, Mark Nixon, Erik A Imel
Published 2021-11-01
Article